NSC 3973 en es it fr

NSC 3973 Brand names, NSC 3973 Analogs

NSC 3973 Brand Names Mixture

  • No information avaliable

NSC 3973 Chemical_Formula


NSC 3973 RX_link

No information avaliable

NSC 3973 fda sheet

NSC 3973 msds (material safety sheet)


NSC 3973 Synthesis Reference

No information avaliable

NSC 3973 Molecular Weight

133.104 g/mol

NSC 3973 Melting Point

230 oC

NSC 3973 H2O Solubility

4.5 g/l

NSC 3973 State


NSC 3973 LogP

-0.67 +/- 0.36

NSC 3973 Dosage Forms

Capsules and powder

NSC 3973 Indication

There is no support for the claim that aspartates are exercise performance enhancers, i.e. ergogenic aids.

NSC 3973 Pharmacology

L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.

NSC 3973 Absorption

Absorbed from the small intestine by an active transport process

NSC 3973 side effects and Toxicity

Mild gastrointestinal side effects including diarrhea. LD50 (rat) > 5,000 mg/kg.

NSC 3973 Patient Information

No information avaliable

NSC 3973 Organisms Affected

Humans and other mammals